Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 3/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | TTR | P02766 | 2/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.45 |
| ▸ | LPAR5 | Q9H1C0 | 6/20 | 0.45 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | RARB | P10826 | 1/20 | 0.38 |
| ▸ | RARG | P13631 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13106027 | 0.86 | ESR1 (0.46) | RXRAESR1ESR2CHRM5BRD4 | |
| SCHEMBL16209977 | 0.86 | ESR1 (0.48) | RXRAESR1ESR2ALDH1A1 | |
| SCHEMBL4891781 | 0.85 | TTR (0.44) | RXRAESR1ESR2TTRSRD5A2 | |
| SCHEMBL13321966 | 0.84 | ESR1 (0.44) | RXRAESR1ESR2TTRGAA | |
| SCHEMBL13106026 | 0.83 | KMT2A (0.48) | RXRAESR1ESR2SRD5A2 | |
| SCHEMBL13321951 | 0.83 | ESR1 (0.43) | RXRAESR1ESR2TTRSRD5A2 | |
| SCHEMBL31147115 | 0.83 | SRD5A2 (0.56) | RXRASRD5A2GAAPKMRXRB | |
| SCHEMBL2707487 | 0.83 | SRD5A2 (0.56) | RXRASRD5A2GAAPKMRXRB | |
| SCHEMBL13106030 | 0.82 | ESR1 (0.43) | RXRAESR1ESR2CHRM5ALDH1A1 | |
| SCHEMBL13321960 | 0.82 | ESR1 (0.43) | ESR1ESR2GAACHRM5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080027244-A1 | Method for Manufacturing Aromatic Dicarboxylic Acid | JFE CHEMICAL CORPORATION (JP) | 2008-01-31 | — | — | US | disclosed |
| EP-1834943-A1 | PROCESS FOR PRODUCING AROMATIC DICARBOXYLIC ACID | JFE Chemical Corporation (JP) | 2007-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027244-A1 | Method for Manufacturing Aromatic Dicarboxylic Acid | DDC, PAH, ALDH7A1 | RXRA 2115/4885ESR1 4756/4885ESR2 4811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.